Thalidomide-associated deep vein thrombosis and pulmonary embolism

[1] ABRAMSON N, 2001, P AN M AM SOC CLIN, V20, pB179

[2] Advances in disease biology: Therapeutic implications [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 6 - 10

[3] INTERFERON-GAMMA MODULATES THE FIBRINOLYTIC RESPONSE IN CULTURED HUMAN ENDOTHELIAL-CELLS [J]. THROMBOSIS RESEARCH, 1995, 77 (05) : 431 - 440

[4] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients [J]. BLOOD, 2001, 98 (02) : 492 - 494

[5] Thalomid® (Thalidomide) capsules -: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing [J]. DRUG SAFETY, 2001, 24 (02) : 87 - 117

[6] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085

[7] DESAI A, 2001, P ASCO, V20, P2448

[8] Thalidomide and venous thrombosis [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (09) : 711 - 711

[9] A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 62 - 66

[10] FINE HA, 2001, P AN M AM SOC CLIN, V20, pA55

[1] ABRAMSON N, 2001, P AN M AM SOC CLIN, V20, pB179

[2] Advances in disease biology: Therapeutic implications [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 6 - 10

[3] INTERFERON-GAMMA MODULATES THE FIBRINOLYTIC RESPONSE IN CULTURED HUMAN ENDOTHELIAL-CELLS [J]. THROMBOSIS RESEARCH, 1995, 77 (05) : 431 - 440

[4] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients [J]. BLOOD, 2001, 98 (02) : 492 - 494

[5] Thalomid® (Thalidomide) capsules -: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing [J]. DRUG SAFETY, 2001, 24 (02) : 87 - 117

[6] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085

[7] DESAI A, 2001, P ASCO, V20, P2448

[8] Thalidomide and venous thrombosis [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (09) : 711 - 711

[9] A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 62 - 66

[10] FINE HA, 2001, P AN M AM SOC CLIN, V20, pA55